Cerebroprotective action of butylphthalide in acute ischemic stroke: Potential role of Nrf2/HO-1 signaling pathway.

Neurotherapeutics

Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, IA, USA.

Published: October 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11585883PMC
http://dx.doi.org/10.1016/j.neurot.2024.e00461DOI Listing

Publication Analysis

Top Keywords

cerebroprotective action
4
action butylphthalide
4
butylphthalide acute
4
acute ischemic
4
ischemic stroke
4
stroke potential
4
potential role
4
role nrf2/ho-1
4
nrf2/ho-1 signaling
4
signaling pathway
4

Similar Publications

Purpose: The incidence of vascular dementia (VaD), as one of the main types of dementia in old age, has been increasing year by year, and exploring its pathogenesis and seeking practical and effective treatment methods are undoubtedly the key to solving this problem. Phosphoglycerate translocase 5 (PGAM5), as a crossroads of multiple signaling pathways, can lead to mitochondrial fission, which in turn triggers the onset and development of necroptosis, and thus PGAM5 may be a novel target for the prevention and treatment of vascular dementia.

Methods: Animal model of vascular dementia was established by Two-vessel occlusion (2-VO) method, and cellular model of vascular dementia was established by oxygen glucose deprivation (OGD) method.

View Article and Find Full Text PDF

The intranasal route of drug administration is characterized by high bioavailability and is considered promising for rapid delivery of drugs with systemic action to the central nervous system (CNS), bypassing the blood-brain barrier. This is particularly important for the use of neuroprotective drugs in the treatment of brain tissue damage in infants caused by the effects of intrauterine hypoxia. The creation of new dosage forms for neonatology using mathematical technologies and special software in pharmaceutical development allows for the creation of cerebroprotective drugs with controlled pharmaco-technological properties, thus reducing time and resources for necessary research.

View Article and Find Full Text PDF

ApTOLL, a TLR4 modulator aptamer, has demonstrated cerebroprotective effects in a permanent ischemic stroke mouse model, as well as safety and efficacy in early phase clinical trials. We carried out reverse translation research according to STAIR recommendations to further characterize the effects and mechanisms of ApTOLL after transient ischemic stroke in rats and to better inform the design of pivotal clinical trials. Adult male rats subjected to transient middle cerebral artery occlusion were treated either with ApTOLL or the vehicle intravenously at different doses and time-points.

View Article and Find Full Text PDF
Article Synopsis
  • Ischaemic encephalopathy is a common cerebrovascular condition linked to chronic diseases like obesity, hypertension, and diabetes, with neurotrophic therapy being the primary treatment method, although it offers limited improvement in neurological function.
  • Previous studies suggest that active ingredients from natural medicines can be beneficial in treating cerebral ischemia, leading researchers to explore heat-clearing herbs for their anti-ischaemic properties.
  • The research involved analyzing 149 prescriptions from various databases, identifying commonly used heat-clearing herbs, and constructing a network that highlights the relationship between herbs, their active ingredients, and targets associated with ischaemic stroke.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!